Page 49 - Jurnal Farmasi Klinik Vol 4 No 1

Jurnal Farmasi Klinik Best Practice Volume 4 No 1

Proc Natl Acad Sci USA between renal NaCl reabsorption

101:17434–17439. and K+ secretion [see comment].

38. Li C, Li Y, Liu H, Sun Z, Lu J, Nat Genet 35:372 376.
Zhao Y (2008) Glucocorticoid 42. Rask E, Olsson T, Soderberg S,

repression of human with-no- Andrew R, Livingstone DE,
lysine (K) kinase-4 gene Johnson O, Walker BR (2001)

expression is mediated by the Tissue-specific dysregulation of

negative response elements in cortisol metabolism in human
the promoter. J Mol Endocrinol obesity. J Clin Endocrinol Metab

40:3–12. 86:1418–1421.
39. Yang CL, Angell J, Mitchell R, 43. Masuzaki H, Paterson J,

Ellison DH (2003) WNK kinases Shinyama H, Morton NM,

regulate thiazide-sensitive Na-Cl Mullins JJ, Seckl JR, Flier JS
cotransport. J Clin Invest (2001) A transgenic model of

111:1039–1045. visceral obesity and the
40. Wilson FH, Disse-Nicodeme S, metabolic syndrome. Science

Choate KA, Ishikawa K, Nelson 294:2166–2170.
Williams C, Desitter I, Gunel M, 44. Paterson JM, Morton NM,

Milford DV, Lipkin GW, Fievet C, Kenyon CJ, Holmes

Achard JM, Feely MP, Dussol B, MC, Staels B, Seckl JR, Mullins
Berland Y, Unwin RJ, Mayan H, JJ (2004) Metabolic syndrome

Simon DB, Farfel Z, without obesity: hepatic
Jeunemaitre X, Lifton RP (2001) overexpression of 11beta-

Human hyperten sion caused by hydroxysteroid dehydrogenase

mutations in WNK kinases. type 1 in transgenic mice. Proc
Science 293:1107 1112. Natl Acad Sci USA 101:7088–

41. Kahle KT, Wilson FH, Leng Q, 7093.
Lalioti MD, O'Connell AD, 45. Lv J, Zhang H, Wong MG, et al.

Dong K, Rapson AK, Effect of Oral

MacGregor GG, Giebisch G, Methylprednisolone on Clinical
Hebert SC, Lifton RP (2003) Outcomes in Patients With IgA

WNK4 regulates the balance Nephropathy: The TESTING

https://jfklin.rsupfatmawati.co.id/jfklin 48